Khosla Ventures related stories
All articles and analysis
- LP corner, week of Aug. 31, 2009
News briefs about LPs New York Common and Pathway Capital
- peHUB Wire: Friday, August 28, 2009
Random Ramblings
- peHUB Wire: Friday, August 28, 2009
Random Ramblings
- From The Filings: VC Deal Scoop
What follows are seven VC deals culled from recent Regulation D filings with the SEC. None of them has been otherwise disclosed: * ValenTx Inc., a Carpinteria, Calif.-based developer of minimally-invasive treatments for morbid obesity, has raised $20.29 million in new VC funding. The company previously raised around $7 million from firms like EDF Ventures, Affinity Capital Management, Kaiser Permanente Ventures, TGap Ventures and Sapient Capital Management. www.valentx.com http://www.valentx.com * Seeo Inc., a Berkeley, Calif.-based lithium-ion battery developer, has raised over $8.6 million in new VC funding. Return backers include Khosla Ventures. www.seeo.com http://www.seeo.com
- peHUB Wire: Tuesday, August 25, 2009
Random Ramblings
- peHUB Wire: Tuesday, August 25, 2009
Random Ramblings
- Georgia On My Mind...
And then there was one... Earlier this month, the Tennessee Consolidated Retirement System made its first-ever dip into private equity waters, committing a total of $150 million to funds managed by Hellman & Friedman, Khosla Ventures and TA Associates. The moves came approximately one year after the Tennessee legislature voted to approve http://www.venturenashville.com/news.php?viewStory=102 alternative asset commitments, making Tennessee the 49th state with such flexibility. The lone holdout is Georgia, which doesn't make alternative investments out of either its public employees' pension system (ERSGA) or its State Treasury. I know that it's a "red" state, but this seems to be taking conservatism a bit too seriously.
- Exit watch, week of Aug. 24, 2009
M&A news briefs about iLike, AirMagnet and TravelGuru
- Amyris Biotech Raising Series C Round
Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has secured $24.75 million of a $62 million Series C round, according to a regulatory filing. The company previously raised more than $120 million, from firms like Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPG Biotech. www.amyrisbiotech.com